[1] |
NAVARRO M A, MCCLANE B A, UZAL F A. Mechanisms of action and cell death associated with Clostridium perfringens toxins[J]. Toxins (Basel), 2018, 10(5):212.
|
[2] |
臧江华, 安一娜, 王 婧, 等. 鸡源A型产气荚膜梭菌致病性及药物疗效分析[J]. 畜牧兽医学报, 2022, 53(10):3561-3569.ZANG J H, AN Y N, WANG J, et al. Investigation on pathogenicity and drug efficacy of Clostridium perfringens type A[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(10):3561-3569. (in Chinese)
|
[3] |
ANJU K, KARTHIK K, DIVYA V, et al. Toxinotyping and molecular characterization of antimicrobial resistance in Clostridium perfringens isolated from different sources of livestock and poultry[J/OL]. Anaerobe. 2021, 67:102298. [2023-03-13]. https://www.sciencedirect.com/science/article/pii/S1075996420301542?via%3Dihub
|
[4] |
NGAMWONGSATIT B, TANOMSRIDACHCHAI W, SUTHIENKUL O, et al. Multidrug resistance in Clostridium perfringens isolated from diarrheal neonatal piglets in Thailand[J]. Anaerobe, 2016, 38:88-93.
|
[5] |
MENG S K, LIN Z B, WANG Y, et al. Psoriasis therapy by Chinese medicine and modern agents[J]. Chin Med, 2018, 13:16.
|
[6] |
LUO H, VONG C T, CHEN H B, et al. Naturally occurring anti-cancer compounds:shining from Chinese herbal medicine[J]. Chin Med, 2019, 14:48.
|
[7] |
WANG L Q, YANG R, YUAN B C, et al. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb[J]. Acta Pharm Sin B, 2015, 5(4):310-315.
|
[8] |
YUAN L W, JIANG X M, XU Y L, et al. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells[J]. Phytomedicine, 2021, 80:153394.
|
[9] |
GAO F, LI M, YU X F, et al. Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells[J]. J Cell Mol Med, 2021, 25(2):813-826.
|
[10] |
TIAN M Y, LI N, LIU R N, et al. The protective effect of licochalcone A against inflammation injury of primary dairy cow claw dermal cells induced by lipopolysaccharide[J]. Sci Rep, 2022, 12(1):1593.
|
[11] |
ZHOU Y, WU R, CAI F F, et al. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis[J]. Pharm Biol, 2021, 59(1):1592-1604.
|
[12] |
LI X J Y, SUN R, LIU R P. Natural products in licorice for the therapy of liver diseases:progress and future opportunities[J]. Pharmacol Res, 2019, 144:210-226.
|
[13] |
ZHAI L, BLOM J, CHEN M, et al. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria[J]. Antimicrob Agents Chemother, 1995, 39(12):2742-2748.
|
[14] |
ASL M N, HOSSEINZADEH H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds[J]. Phytother Res, 2008, 22(6):709-724.
|
[15] |
MESSIER C, GRENIER D. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans[J]. Mycoses, 2011, 54(6):e801-e806.
|
[16] |
TSUKIYAMA R I, KATSURA H, TOKURIKI N, et al. Antibacterial activity of licochalcone A against spore-forming bacteria[J]. Antimicrob Agents Chemother, 2002, 46(5):1226-1230.
|
[17] |
HAO H J, HUI W J, LIU P, et al. Effect of licochalcone A on growth and properties of Streptococcus suis[J]. PLoS One, 2013, 8(7):e67728.
|
[18] |
刘宗争. 甘草查尔酮A对产气荚膜梭菌感染的治疗作用及应用[D]. 长春:吉林大学, 2019.LIU Z Z. Therapeutic effect and application of licochalcone A against Clostridium perfringens infection[D]. Changchun:Jilin University, 2019. (in Chinese)
|
[19] |
LUO W H, QIN H, CHEN D M, et al. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model[J]. Microb Pathog, 2020, 147:104389.
|
[20] |
XIONG J C, ZHU Q Q, ZHAO Y X, et al. Tilmicosin enteric granules and premix to pigs:antimicrobial susceptibility testing and comparative pharmacokinetics[J]. J Vet Pharmacol Ther, 2019, 42(3):336-345.
|
[21] |
CAO Y M, LEI E, WANG X L, et al. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo[J]. Antiviral Res, 2021, 195:105091.
|
[22] |
MENDEZ M, HUANG I H, OHTANI K, et al. Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens[J]. J Bacteriol, 2008, 190(1):48-60.
|
[23] |
MATTICK J S. Type IV pili and twitching motility[J]. Annu Rev Microbiol, 2002, 56:289-314.
|
[24] |
PIEPENBRINK K H, SUNDBERG E J. Motility and adhesion through type IV pili in gram-positive bacteria[J]. Biochem Soc Trans, 2016, 44(6):1659-1666.
|
[25] |
吴玉臣, 朱先鹏, 李有志, 等. 侧柏叶颗粒剂对产气荚膜梭菌Ⅳ型菌毛系统功能的抑制作用及其机制[J]. 中国兽医学报, 2022:1-6.WU Y C, ZHU X P, LI Y Z, et al. Inhibitory effect and action mechanism of Platycladi cacumen granules on type Ⅳ pili of Clostridium perfringens[J]. Chinese Journal of Veterinary Science, 2022:1-6. (in Chinese)
|
[26] |
GUAN S, SONG Y, GUO W X, et al. Immunosuppressive activity of tilmicosin on the immune responses in mice[J]. Immunopharmacol Immunotoxicol, 2011, 33(2):323-328.
|
[27] |
MARKEY L, PUGLIESE A, TIAN T, et al. Decreased ecological resistance of the gut microbiota in response to clindamycin challenge in mice colonized with the fungus Candida albicans[J]. mSphere, 2021, 6(1):e00982-20.
|
[28] |
PEUKERT K, FOX M, SCHULZ S, et al. Inhibition of caspase-1 with tetracycline ameliorates acute lung injury[J]. Am J Respir Crit Care Med, 2021, 204(1):53-63.
|
[29] |
陈环环. 甘草查尔酮A及木犀草素联合抗菌药对鸡源大肠杆菌的抑制作用[D]. 郑州:河南农业大学, 2021.CHEN H H. Inhibitory effect of licorice chalcone A and luteolin combined with antimicrobial on chicken Escherichia coli[D]. Zhengzhou:Henan Agricultural University, 2021. (in Chinese)
|
[30] |
WU S C, YANG Z Q, LIU F, et al. Antibacterial effect and mode of action of flavonoids from licorice against methicillin-resistant Staphylococcus aureus[J]. Front Microbiol, 2019, 10:2489.
|
[31] |
郭晋祥, 吕会茹, 李姣锋, 等. 甘草查耳酮A对貂源铜绿假单胞菌的抗菌活性[J]. 中国畜牧兽医, 2022, 49(3):1181-1188.GUO J X, LV H R, LI J F, et al. Antibacterial activity of licochalcone A against Pseudomonas aeruginosa isolated from mink[J]. China Animal Husbandry & Veterinary Medicine, 2022, 49(3):1181-1188. (in Chinese)
|
[32] |
FRIIS-MØLLER A, CHEN M, FUURSTED K, et al. In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots[J]. Planta Med, 2002, 68(5):416-419.
|
[33] |
LIU X, XIONG Y, SHI Y, et al. In vitro activities of licochalcone A against planktonic cells and biofilm of Enterococcus faecalis[J]. Front Microbiol, 2022, 13:970901.
|
[34] |
HARAGUCHI H, TANIMOTO K, TAMURA Y, et al. Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata[J]. Phytochemistry, 1998, 48(1):125-129.
|
[35] |
吴玉霞. 中药泽漆抗菌活性成分研究[D]. 昆明:云南中医药大学, 2020.WU Y X. Study on antibacterial active constituents from traditional Chinese medicine Euphorbia helioscopia Linn[D]. Kunming:Yunnan University of Chinese Medicine, 2020. (in Chinese)
|
[36] |
刘一宁. 桔梗汤抗金葡菌感染致急性肺损伤及其药效成分研究[D]. 杭州:浙江大学, 2018.LIU Y N. Study on the effect of Jie-geng-tang on Staphylococcus aureus-induced acute lung injury its efficacy constituents[D]. Hangzhou:Zhejiang University, 2018. (in Chinese)
|
[37] |
QIU J Z, FENG H H, XIANG H, et al. Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by Staphylococcus aureus[J]. FEMS Microbiol Lett, 2010, 307(2):135-141.
|
[38] |
BROOK I. Spectrum and treatment of anaerobic infections[J]. J Infect Chemother, 2016, 22(1):1-13.
|
[39] |
ROBERTS M C, SCHWARZ S. Tetracycline and phenicol resistance genes and mechanisms:importance for agriculture, the environment, and humans[J]. J Environ Qual, 2016, 45(2):576-592.
|
[40] |
MILANOVIĆ V, MAOLONI A, BELLEGGIA L, et al. Tetracycline resistance genes in the traditional Swedish sour herring surströmming as revealed using qPCR[J]. Genes (Basel), 2022, 14(1):56.
|
[41] |
XU D M, XIAO Y P, PAN H, et al. Toxic effects of tetracycline and its degradation products on freshwater green algae[J]. Ecotoxicol Environ Saf, 2019, 174:43-47.
|